Selection of CMY-2 producing Escherichia coli in the faecal flora of dogs treated with cephalexin

Veterinary Microbiology

Volumn 151, Issue 3-4, 2011, Pages 404-408

  Damborg, Peter ^a   Gaustad, Ingrid B ^a   Olsen, John E ^a   Guardabassi, Luca ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Lactams; AmpC; Antibiotic resistance; Antibiotic therapy; Companion animals

Indexed keywords

AMIKACIN; BETA LACTAMASE CMY; CEFALEXIN; CEFOTAXIME; ENROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; COHORT ANALYSIS; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EXPERIMENTAL DOG; FECES MICROFLORA; FEMALE; IN VIVO STUDY; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PYODERMA; REPLICON; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALEXIN; COHORT STUDIES; DNA, BACTERIAL; DOG DISEASES; DOGS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; MALE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PLASMIDS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PYODERMA;

ANIMALIA; CANIS FAMILIARIS; ESCHERICHIA COLI;

EID: 79960182530     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.03.015     Document Type: Article

References (32)

1. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., Threlfall E.J. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Meth. 2005, 63:219-228.
2. Carattoli A., Lovari S., Franco A., Cordaro G., Di Matteo P., Battisti A. Extended-spectrum β-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob. Agents Chemother. 2005, 49:833-835.
3. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 2009, 53:2227-2238.
4. Cavaco L.M., Abatih E., Aarestrup F.M., Guardabassi L. Selection and persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome. Antimicrob. Agents Chemother. 2008, 32:3612-3616.
5. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000, 66:4555-4558.
6. Clinical Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved standard, third ed., M31-A3, vol. 28, no. 8 2008, CLSI, Wayne, PA, USA.
7. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18, vol. 28, no. 1 2008, CLSI, Wayne, PA, USA.
8. Costa D., Poeta P., Brinas L., Saenz Y., Rodrigues J., Torres C. Detection of CTX-M-1 and TEM-52 beta-lactamases in Escherichia coli strains from healthy pets in Portugal. J. Antimicrob. Chemother. 2004, 54:960-961.
9. Damborg P., Nielsen S.S., Guardabassi L. Escherichia coli shedding patterns in humans and dogs: insight into within-household sharing of phylotypes associated with urinary tract infections. Epidemiol. Infect. 2009, 137:1457-1464.
10. DANMAP, 2004 and 2009. Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Foods and Humans in Denmark. Copenhagen, Denmark, 2005 and 2010. , ISSN 1600-2032. http://www.vet.dtu.dk/.
11. García-Fernández A., Chiaretto G., Bertini A., Villa L., Fortini D., Ricci A., Carattoli A. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum beta-lactamases in Escherichia coli and Salmonella of human and animal origin. J. Antimicrob. Chemother. 2008, 61:1229-1233.
12. Goodyear K. Sales of Antimicrobial Products Authorised for use as Veterinary Medicines, Antiprotozoals, Antifungals, Growth Promoters and Coccidiostats in the UK in 2009 2010, Veterinary Medicines Directorate, Day last visited: November 23rd, 2010. http://www.vmd.gov.uk/Publications/Antibiotic/salesanti09.pdf.
13. Grønvold A.R., L'Abée-Lund T.M., Sørum H., Skancke E., Yannarell A.C., Mackie R.I. Changes in fecal microbiota of healthy dogs administered amoxicillin. FEMS Microbiol. Ecol. 2010, 71:313-326.
14. Hasman H., Mevius D., Veldman K., Olesen I., Aarestrup F.M. Beta-lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J. Antimicrob. Chemother. 2005, 56:115-121.
15. Jernberg C., Löfmark S., Edlund C., Jansson J.K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007, 1:56-66.
16. Johnson J.R., Gajewski A., Lesse A.J., Russo T.A. Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J. Clin. Microbiol. 2003, 41:5798-5802.
17. Johnson J.R., Russo T.A. Extraintestinal pathogenic Escherichia coli: " the other bad E. coli" J. Lab. Clin. Med. 2001, 139:155-162.
18. Jørgensen R.L., Nielsen J.B., Friis-Moller A., Fjeldsoe-Nielsen H., Schonning K. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype. J. Antimicrob. Chemother. 2010, 65:460-464.
19. Mataseje L.F., Baudry P.J., Zhanel G.G., Morck D.W., Read R.R., Louie M., Mulvey M.R. Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada. Diagn. Microbiol. Infect. Dis. 2010, 67:387-391.
20. McLellan S.L., Daniels A.D., Salmore A.K. Genetic characterization of Escherichia coli populations from host sources of fecal pollution by using DNA fingerprinting. Appl. Environ. Microbiol. 2003, 69:2587-2594.
21. Mentula S., Harmoinen J., Koski P., Westermarck E., Rautio M., Huovinen P., Könönen E. Inhibition of ampicillin-induced emergence of resistance in intestinal coliforms by targeted recombinant beta-lactamase. Int. J. Antimicrob. Agents 2004, 24:555-561.
22. Murphy C., Reid-Smith R.J., Prescott J.F., Bonnett B.N., Poppe C., Boerlin P., Weese J.S., Janecko N., McEwen S.A. Occurrence of antimicrobial resistant bacteria in healthy dogs and cats presented to private veterinary hospitals in southern Ontario: a preliminary study. Can. Vet. J. 2009, 50:1047-1053.
23. Naseer U., Haldorsen B., Simonsen G.S., Sundsfjord A. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Clin. Microbiol. Infect. 2010, 16:171-178.
24. O'Keefe A., Hutton T.A., Schifferli D.M., Rankin S.C. First detection of CTX-M and SHV extended-spectrum β-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States. Antimicrob. Agents Chemother. 2010, 54:3489-3492.
25. Oteo J., Cercenado E., Cuevas O., Bautista V., Delgado-Iribarren A., Orden B., Pérez-Vázquez M., García-Cobos S., Campos J. AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131. Diagn. Microbiol. Infect. Dis. 2010, 67:270-276.
26. Pérez-Pérez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002, 40:2153-2162.
27. Rantala M., Hölsö K., Lillas A., Huovinen P., Kaartinen L. Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital. Vet. Rec. 2004, 155:259-262.
28. Sanchez S., McCrackin Stevenson M.A., Hudson C.R., Maier M., Buffington T., Dam Q., Maurer J.J. Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs. J. Clin. Microbiol. 2002, 40:3586-3595.
29. CMY-7 and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia. J. Antimicrob. Chemother. 2006, 57:840-848.
30. Singer R.S., Patterson S.K., Wallace R.L. Effects of therapeutic ceftiofur administration to dairy cattle on Escherichia coli dynamics in the intestinal tract. Appl. Environ. Microbiol. 2008, 74:6956-6962.
31. SVARM, 2005. Swedish Veterinary Antimicrobial Resistance Monitoring. Uppsala, Sweden, 2006. , ISSN 1650-6332. http://www.sva.se/.
32. Winokur P.L., Vonstein D.L., Hoffman L.J., Uhlenhopp E.K., Doern G.V. Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 2001, 45:2716-2722.